Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-01-29 @ 3:48 AM
Study NCT ID:
NCT04226066
Status:
UNKNOWN
Last Update Posted:
2020-12-07
First Post:
2019-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors
Sponsor:
Tasly Tianjin Biopharmaceutical Co., Ltd.
Organization: